Chai Discovery Builds AI Protein Design Platform
Chai Discovery is positioning AI protein design as a neutral software factory for pharma partners. The company has partnered with Eli Lilly, Pfizer, Novartis, and Argenx to accelerate antibody and binder discovery. Its visual design suite, compute infrastructure, and partner specific fine tuning create a platform model for precision drug engineering.